Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Does This Prove that Obamacare Was a Success?

Obamacare has been the biggest headline in health care news since before the law got passed. From the disastrous rollout of health to the pitched political battles in Congress, the law has been a huge news item that everyone has wanted to know more about.

And finally, we have some insight into why the Obamacare exchanges enrolled so many people.

Simply put, a lot of people signed up -- over 8 million. More even than Obamacare bulls expected -- more even than Health and Human Services had hoped for.

And, according to the early numbers we've heard from insurers, most people (around 80%) are paying their premiums. So the vast majority of those sign-ups look likely to stick. What's more, according to a recent poll from the Henry J. Kaiser Family Foundation, about 60% of enrollees didn't previously have insurance, and according to a recent Gallup poll, those newly enrolled on the exchanges skew younger than the age distribution of the U.S. population.

But, of course, let's not forget the (truncated) official name of Obamacare -- the Affordable Care Act (emphasis mine).

Did the law succeed in making insurance, well, affordable? And what part did the infamous government subsidies play? In the video below, health care analysts Michael Douglass and David Williamson share exciting data that may help answer these crucial questions.

Obamacare is yesterday's news. This could be tomorrow's.
Obamacare is a huge headline, but that means that everyone's already aware of it -- and the stocks most poised to benefit have already seen their share prices run up. The best investors consistently reap gigantic profits by recognizing true potential earlier and more accurately than anyone else. Let me cut right to the chase. There is a product in development that will revolutionize not how we treat a common chronic illness, but potentially the entire health industry. Analysts are already licking their chops at the sales potential. In order to outsmart Wall Street and realize multi-bagger returns you will need The Motley Fool's new free report on the dream-team responsible for this game-changing blockbuster. CLICK HERE NOW.

Read/Post Comments (0) | Recommend This Article (2)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 3011957, ~/Articles/ArticleHandler.aspx, 9/1/2015 3:58:40 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Michael Douglass

As the Motley Fool's Health Care Editor/Analyst, I focus on all things health care -- although my greatest interest is in the megatrends reshaping the American health care system, including the Affordable Care Act, Accountable Care Organizations, a shifting regulatory landscape, and the new drug discoveries fundamentally changing disease management and treatment.

Today's Market

updated 6 hours ago Sponsored by:
DOW 16,528.03 -114.98 -0.69%
S&P 500 1,972.18 -16.69 -0.84%
NASD 4,776.51 -51.82 -1.07%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

8/31/2015 4:01 PM
ANTM $141.05 Up +0.49 +0.35%
Anthem CAPS Rating: ****
UNH $115.70 Down -1.58 -1.35%
UnitedHealth Group CAPS Rating: *****